1. Home
  2. ARCC vs SNN Comparison

ARCC vs SNN Comparison

Compare ARCC & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ares Capital Corporation

ARCC

Ares Capital Corporation

HOLD

Current Price

$19.27

Market Cap

13.4B

Sector

Finance

ML Signal

HOLD

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$31.22

Market Cap

14.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCC
SNN
Founded
2004
1856
Country
United States
United Kingdom
Employees
N/A
16988
Industry
Finance/Investors Services
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4B
14.3B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
ARCC
SNN
Price
$19.27
$31.22
Analyst Decision
Buy
Hold
Analyst Count
11
2
Target Price
$21.36
$36.25
AVG Volume (30 Days)
6.3M
1.0M
Earning Date
04-28-2026
03-16-2026
Dividend Yield
10.28%
2.48%
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
N/A
N/A
Revenue This Year
$5.77
$8.58
Revenue Next Year
$2.29
$5.60
P/E Ratio
$147.35
$64.97
Revenue Growth
N/A
N/A
52 Week Low
$17.40
$28.02
52 Week High
$23.42
$38.79

Technical Indicators

Market Signals
Indicator
ARCC
SNN
Relative Strength Index (RSI) 59.72 39.57
Support Level $18.78 N/A
Resistance Level $19.43 $33.89
Average True Range (ATR) 0.38 0.57
MACD 0.06 -0.24
Stochastic Oscillator 85.54 18.00

Price Performance

Historical Comparison
ARCC
SNN

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: